БЛОГ

Archive for the ‘biotech/medical’ category: Page 14

Dec 9, 2024

Scientists discover more mitochondria-like symbionts with surprising metabolic capacities

Posted by in category: biotech/medical

In 2021, scientists at the Max Planck Institute for Marine Microbiology in Bremen, Germany, reported an astonishing new form of symbiosis: They found a unique bacterium that lives inside a ciliate—a unicellular eukaryote—and provides it with energy. The symbiont’s role is thus strongly reminiscent of mitochondria, with the key difference that the endosymbiont derives energy from the respiration of nitrate, not oxygen.

Now the researchers from Bremen set out to learn more about the environmental distribution and diversity of these peculiar symbionts. “After our initial discovery of this in a freshwater lake, we wondered how common these organisms are in nature,” says Jana Milucka from the Max Planck Institute for Marine Microbiology. “Are they extremely rare and therefore eluded detection so long? Or do they exist elsewhere and if so, what are their metabolic capacities?”

Dec 9, 2024

How Evolution Shaped the Brain’s Understanding of Numbers

Posted by in categories: biotech/medical, evolution, mathematics, neuroscience

Summary: Human number cognition may be rooted in the putamen, a deep brain structure traditionally associated with movement rather than abstract thought. Neurosurgery patients demonstrated activity in this area while processing numbers as symbols, words, and concepts, suggesting that numerical understanding emerged early in evolution.

Researchers also observed activity in expected areas like the parietal lobe, highlighting how different brain regions collaborate in number processing. These findings could improve surgical outcomes by protecting areas crucial for number cognition and open pathways to enhancing math learning through targeted interventions.

Dec 9, 2024

Next-Generation Size Selection for Optimized Long-Read Sequencing Workflow

Posted by in categories: biotech/medical, health, information science

All DNA is prone to fragmentation, whether it is derived from a biological matrix or created during gene synthesis; thus, any DNA sample will contain a range of fragment sizes. To really exploit the true benefits of long read sequencing, it is necessary to remove these shorter fragments, which might other wise be sequenced preferentially.

DNA size selection can exclude short fragments, maximizing data yields by ensuring that those fragments with the most informational content are not blocked from accessing detection centers (for example, ZMWs) by shorter DNA fragments.

Next-generation size-selection solutions Starting with clean, appropriate-length fragments for HiFi reads can accelerate research by reducing the computation and data processing time needed post-sequencing. Ranger Technology from Yourgene Health is a patent-protected process for automating electrophoresis-based DNA analysis and size selection. Its fluorescence machine vision system and image analysis algorithms provide real-time interpretation of the DNA separation process.

Dec 9, 2024

Chatbot gives medical advice to hundreds of users in largest trial yet

Posted by in categories: biotech/medical, robotics/AI

Users of the healthcare app Alan whose queries were answered by a medical AI reported high satisfaction levels, but one exchange included “potentially dangerous inaccuracies”

Dec 9, 2024

FDA Approves New Cancer Treatments

Posted by in categories: biotech/medical, genetics

In August, the Food and Drug Administration (FDA) granted accelerated approval of Tecelra (afamitresgene autoleucel)— the first T-cell receptor therapy for solid tumors—for people with inoperable or metastatic synovial sarcoma. Tecelra is a gene therapy created from a patient’s own T cells. A sample of cells is removed and genetically modified to express a natural T-cell receptor that targets MAGE-A4, an antigen expressed on cancer cells. In the Phase II SPEARHEAD-1 trial, the overall response rate was 43%, and 39% of responders were still doing well a year later.

Dec 9, 2024

Short Sleep and High Blood Pressure Linked to Brain Aging

Posted by in categories: biotech/medical, life extension, neuroscience

Summary: Research reveals that people with high blood pressure who also sleep less than six hours per night face increased risks of brain injury, accelerated brain aging, and impaired executive function. The study assessed 682 participants from the Framingham Heart Study, analyzing sleep patterns, blood pressure, cognitive performance, and brain MRIs.

These risks were not present in individuals with normal blood pressure, highlighting a concerning interaction between sleep deprivation and hypertension. Researchers suggest treating sleep problems and hypertension as potential interventions to protect brain health and delay cognitive decline.

Dec 9, 2024

Efficient Liposome Loading onto Surface of Mesenchymal Stem Cells via Electrostatic Interactions for Tumor-Targeted Drug Delivery

Posted by in category: biotech/medical

📝 — Kono, et al.

In this paper, the authors attempted to load liposomes on the surface of MSCs by using the magnetic anionic liposome/atelocollagen complexes that we previously developed and assessed the characters of liposome-loaded MSCs as drug carriers.

Full text is available 👇

Continue reading “Efficient Liposome Loading onto Surface of Mesenchymal Stem Cells via Electrostatic Interactions for Tumor-Targeted Drug Delivery” »

Dec 9, 2024

Molecule Implicated in Regulating Immunotherapy Resistance

Posted by in category: biotech/medical

Cancer cells have evolved sophisticated strategies to evade the immune system, prolonging their survival and growth. They have also developed survival tactics to resist immune checkpoint inhibition (ICI) treatments. Yet, our understanding of how cancer cells escape the immune response or immune activities perpetuated by anti-cancer immunotherapies remains incomplete. A recent study published in Cancer Discovery has shed light on one such mechanism, revealing how tumors develop ICI resistance and enhancing our understanding of cancer immunotherapy.

The researchers screened 208 metastatic castration-resistant prostate cancer (mCRPC) biopsies searching for genes commonly observed in tumors. Once they identified candidate genes, the investigators compared their expression to that of signatures related to cytotoxic T cells (CTLs), the immune cell subset responsible for identifying and killing cancer cells. The analysis identified an enzyme, ubiquitin-like modifier activating enzyme 1 (UBA1), which the researchers found particularly interesting. Tumors with high expression of UBA1 had low expression of CTL genes.

Further investigation revealed that elevated UBA1 expression predicted which tumors would develop resistance to ICI and which patients would experience the shortest survival outcomes.

Dec 9, 2024

A squid-inspired medical device could reduce the need for needles

Posted by in category: biotech/medical

The device, which directs a liquid by mimicking squids’ high-pressure jets, could provide alternative delivery methods for injectable drugs.

Dec 9, 2024

Targeting novel molecular mechanisms may repair damaged DNA in cancer cells

Posted by in categories: biotech/medical, genetics

Northwestern Medicine investigators have discovered new molecular mechanisms underlying DNA repair dysregulation in prostate cancer cells, findings that may inform the development of new targeted therapies for patients that have become resistant to standard treatments, according to a recent study published in Science Advances.

Qi Cao, Ph.D., the Anthony J. Schaeffer, MD, Professor of Urology, was senior author of the study.

DNA damage is a natural occurrence in cells caused by various intercellular and external stressors. However, if left unrepaired, this damage can lead to genetic mutations that can lead to the development of different diseases, including cancer.

Page 14 of 2,787First1112131415161718Last